Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-020173
Filing Date
2014-05-19
Accepted
2014-05-19 16:12:08
Documents
1
Period of Report
2014-05-15

Document Format Files

Seq Description Document Type Size
1 CHAPLIN FORM 4 rrd409733.html 4  
1 CHAPLIN FORM 4 rrd409733.xml 4 4271
  Complete submission text file 0001181431-14-020173.txt   5498
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
CHAPLIN DAVID (Reporting) CIK: 0001167232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 14854756